MIR6807

Across TCGA pan-cancer cohorts, MIR6807 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated MIR6807 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher MIR6807 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR6807 expression acts as an unfavorable survival marker, although some lineages such as PAAD and UCEC show a favorable association.

BRCA, MESO, and OV are the cancer types where MIR6807 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Tertile	All	0.880	0.956	<.001	78	view →
MESO	OS	Tertile	IV	0.203	0.661	.003	72	view →
OV	OS	Tertile	IV	0.076	0.759	.014	72	view →
THYM	DFS	Tertile	II,III,IV	0.731	0.962	<.001	64	view →
COAD	OS	Tertile	II,III,IV	0.642	0.845	.001	48	view →
STAD	OS	Tertile	II,III,IV	0.238	0.599	.018	27	view →
ACC	DFS	Tertile	IV	0.012	0.310	.002	27	view →
SARC	DFS	Tertile	All	0.153	0.377	.001	27	view →
UVM	OS	Tertile	All	0.474	0.726	.026	18	view →
CESC	OS	Tertile	IV	0.257	0.627	.033	18	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	15	view →
KIRC	OS	Tertile	All	0.711	0.822	.029	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

MIR6807–BRCA (DFS)

Open the BRCA breakdown →